SMTL ID : 6s9w.1

Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 16a

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x L1Z: ~{N}-[3-[1-[[4-(5-methyl-6-oxidanylidene-3-phenyl-1~{H}-pyrazin-2-yl)phenyl]methyl]piperidin-4-yl]-2-oxidanylidene-1~{H}-benzimidazol-5-yl]propanamide(Covalent)

L1Z.1: 17 residues within 4Å: Chain A: E.17, Y.18, W.80, I.84, L.210, T.211, L.264, K.268, V.270, Y.272, R.273, D.274, I.290, D.292, C.296, K.297, C.310 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:Y.18, A:W.80, A:I.84, A:L.210, A:L.210, A:L.264, A:K.268, A:V.270, A:Y.272, A:D.292 Hydrogen bonds: A:K.297 Water bridges: A:N.54 Salt bridges: A:D.274 pi-Stacking: A:W.80 pi-Cation interactions: A:R.273

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Quambusch, L. et al., Covalent-Allosteric Inhibitors to Achieve Akt Isoform-Selectivity. Angew.Chem.Int.Ed.Engl. (2019)

Release Date

2019-10-16

Peptides

RAC-alpha serine/threonine-protein kinase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

RAC-alpha serine/threonine-protein kinase

Related Entries With Identical Sequence